Top Stories

• 

  Matt Hancock Wins Libel Fight Over 'Antisemitic' COVID Tweet

  By Robbie Kalus

  Matt Hancock defeated a libel claim Wednesday when a London appeals court ruled that the former U.K. health secr...(read more)

• 

  Bahrain Spyware Ruling Opens Door To State Hack Claims

  By Joanne Faulkner

  A decision by the U.K. Supreme Court to allow two Bahraini dissidents to sue the Gulf state over alleged spyware...(read more)

• Billionaire Sheikh Can't Duck Service Of €83M Debt Claim

  By Robbie Kalus

  A Saudi sheikh who owes liquidators €83 million ($95 million) failed on Wednesday to frustrate possession proceedings against his home on Britain's most expensive street, as a London court ruled that the claim forms could be served to his solicitors.

• Macfarlanes Posts Turnover Of £390M In 'Transitional' Year

  By Ashish Sareen

  Macfarlanes LLP said Wednesday that its turnover hit a record £389.5 million ($518.4 million), profits rose 3%, and profit per partner remained flat in what it described as "a transitional year" amid a challenging market backdrop.

• TUI Defeats Pilots' Challenge Over Union-Backed Benefit Cuts

  By Eddie Beaver

  Travel company TUI lawfully reduced long-term illness benefits for a group of pilots receiving income protection payments because the changes were made through a collective agreement with their union rather than being imposed unilaterally, an appeals court ruled Wednesday.

• Major Banks Face Fresh Bid For Opt-In FX Rigging Claim

  By Eddie Beaver

  A competition law consultant sought Wednesday to revive his proposed foreign exchange-rigging class action against major banks, arguing that material changes since its rejection as an opt-out action warrant a fresh opt-in bid.

• Meta Fails To Cut Novel Damages From Facebook Data Claim

  By Joanne Faulkner

  Meta lost on Wednesday its appeal seeking to prevent millions of Facebook users from seeking so-called user damages for the use of their personal data as part of a landmark competition claim.

• Sullivan & Cromwell Aids Apax's €1.5B Packing Cos. Purchase

  By Najiyya Budaly

  Private equity firm Apax Partners LLP will buy two businesses from Gerresheimer AG of Germany for €1.5 billion ($1.7 billion), the companies said Wednesday, as they seek expansion for the pharmaceutical packaging companies in the U.S.

• Glencore Fights To Recoup $230M In Prax Oil Fraud Row

  By Ronan Barnard

  Glencore PLC's U.K. arm asked a London judge Tuesday to let it bring a claim against the collapsed former owner of one of the U.K.'s largest oil refineries, alleging it was defrauded out of $230 million worth of crude oil.

• Patent Pools Must Brace For Litigation After Tesla Ruling

  By Alex Baldwin

  The U.K.'s top court has paved the way for companies that rely on technological standards to rope patent pool operators into litigation to secure fair, reasonable and nondiscriminatory licensing terms after Tesla prevailed in its landmark appeal over wireless technology Monday.

• Right-To-Work Fines Ruling Unlikely To Slow UK Crackdown

  By Adele Redmond

  The Home Office will change its administration of illegal working fines following the top U.K. court's Monday ruling that the department must specify how employers have broken the law — but the decision is unlikely to impede a ramp-up in immigration enforcement.

• Teacher Fired In Trans Pronoun Dispute Presses Ban Appeal

  By Max Austin

  A former teacher has said he can appeal a ban preventing him from working with children after a judge held that a government background check agency may have failed to properly explain why his gender-critical views posed a risk to students.

• Ex-Solicitor Loses Appeal In SFO Tipping-Off Case

  By Christopher Crosby

  A former solicitor was denied an opportunity on Tuesday to overturn his conviction for tipping off a client about an anti-money laundering investigation by the Serious Fraud Office as an appeals court ruled that there was no procedural unfairness in his trial.

• CMA Wins Drug Price Appeal But £100M Fines Face Review

  By Eddie Beaver

  An appeals court upheld on Tuesday findings by a competition tribunal that a group of pharmaceutical companies abused its dominant position to overcharge for a life-saving adrenal drug, but sent approximately £100 million ($133 million) in penalties back for reconsideration.